SMT, PCB Electronics Industry News

Rapid Response Strep A Tests

Oct 16, 2009

BTNX’S Rapid Response® Strep A test is a qualitative lateral flow immunoassay for the detection of group A streptococcus, or group A strep, carbohydrate antigen in a throat swab for professional in-vitro diagnostic.

Toronto, Canada – BTNX Inc. has launched a Rapid Response® advanced FDA cleared & CLIA waived in-vitro diagnostic group A streptococcus, or strep A, test, which is a qualitative lateral flow immunoassay for the detection of strep A carbohydrate antigen in a throat swab.

Strep A is a bacterium that is commonly found in the throat and on the skin. Strep A bacteria might cause no symptoms of disease, but they can also cause infections that range from mild to life-threatening.

Strep A bacteria are spread by direct person-to-person contact. The bacteria are carried in discharges from nose or throat of an infected person and in infected wounds or sores on the skin. The bacteria are usually spread when infected secretions come in the contact with the mouth, nose, or eyes of an uninfected person.

Strep A bacteria usually causes relatively mild illnesses, such as streptococcal sore throat (strep throat) and streptococcal skin infections (impetigo). It can also cause more serious illnesses such as scarlet fever, rheumatic fever, postpartum fever, wound infections, and pneumonia.

Occasionally, a deadly type of strep A bacteria can invade the blood, muscle and fat tissue, or lungs and cause a serious and often life- threatening type infections.

Rapid Response® Strep A test is FDA cleared and CLIA waived, offers 95% accuracy v/s culture (gold Stand) in rare and 1+ colonies and results within 5 minutes, and has no cross reaction with other ?-hemolytic streptococci.

Rapid Response® branded tests are trusted by professionals in laboratories, physicians’ offices, hospitals and clinics worldwide for their diagnostic testing requirements.

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physicians’ offices.

For more information about the products please visit http://www.BTNX.com , or contact Sales@BTNX.com.

Oct 16, 2009 -

Rapid Response® Point of Care Drugs of Abuse Tests

Oct 16, 2009 -

BTNX Offers Free Blood Glucose Meters

Sep 26, 2017 -

Saelig Introduces Wireless 30MHz Scope-In-A-Probe

Sep 26, 2017 -

Sypris Electronics Selling Surplus Assets

Sep 25, 2017 -

Under what circumstances can a tantalum capacitor used instead of an aluminum electrolytic capacitor?

Sep 25, 2017 -

SMART Group and NPL Host Process, Design & Reliability Seminar

Sep 25, 2017 -

Most Technologically Advanced X-ray Cabinet from Scienscope at the Quality Show

Sep 25, 2017 -

Acculogic Offers Production Board Test Systems for the Automotive Industry

Sep 25, 2017 -

IMAPS 2017-Raleigh 2 weeks away, visit YINCAE Booth 416

Sep 25, 2017 -

Gen3 Systems newly appointed Distributor for Nordson SELECT Selective Soldering Equipment

Sep 24, 2017 -

Europlacer Shows Printer at Productronica India – Just!

Sep 24, 2017 -

Microtronic GmbH Appoints Distributor for the LBT210 & ConTTest Systems in Spain and Portugal

See electronics manufacturing industry news »

Rapid Response Strep A Tests news release has been viewed 683 times

Universal GSM2 Feeders

Selective Conformal Coating System - GPD SimpleCoat